Concourse Financial Group Securities, Inc. Vyant Bio, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$0.52 - $0.89 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.62 - $1.37 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$0.99 - $1.61 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$1.32 - $2.96 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$2.26 - $3.74 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$2.88 - $4.81 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$2.89 - $8.6 $0 - $0
0 New
0 $0

Others Institutions Holding VYNT

# of Institutions
2
Shares Held
213K
Call Options Held
0
Put Options Held
0
View Full List

About Vyant Bio, Inc.

VYNT Quotes by TradingView
  • Ticker VYNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,343,200
  • Description
  • Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...
More about VYNT
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email